Passage Bio Inc (NASDAQ:PASG) shares traded -5.86% lower at $0.66 on Wall Street last session.
PASG stock price is now -3.00% away from the 50-day moving average and -26.27% away from the 200-day moving average. The market capitalization of the company currently stands at $40.71M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On September 03, 2024, Rodman & Renshaw recently initiated its ‘Buy’ rating on the stock quoting a target price of $7, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, ORBIMED ADVISORS LLC, 10% Owner sold 75,007 shares of the company’s stock on Jan 08 ’25. The stock was sold for $51,005 at an average price of $0.68. Upon completion of the transaction, the 10% Owner now directly owns 7,257,845 shares in the company, valued at $4.79 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 07 ’25, 10% Owner ORBIMED ADVISORS LLC sold 52,536 shares of the business’s stock. A total of $37,301 was realized by selling the stock at an average price of $0.71. This leaves the insider owning 7,332,852 shares of the company worth $4.84 million. A total of 16.53% of the company’s stock is owned by insiders.
During the past 12 months, Passage Bio Inc has had a low of $0.45 and a high of $1.79. As of last week, the company has a debt-to-equity ratio of 0.36, a current ratio of 5.15, and a quick ratio of 5.15. The fifty day moving average price for PASG is $0.67826 and a two-hundred day moving average price translates $0.897435 for the stock.
The latest earnings results from Passage Bio Inc (NASDAQ: PASG) was released for 2024-06-30.
